- Home
- YYGH vs LUMO Comparison
YYGH vs LUMO Comparison
Compare YYGH & LUMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YYGH
- LUMO
- Stock Information
- Founded
- YYGH 2010
- LUMO 2011
- Country
- YYGH Singapore
- LUMO United States
- Employees
- YYGH N/A
- LUMO N/A
- Industry
- YYGH
- LUMO Biotechnology: Pharmaceutical Preparations
- Sector
- YYGH
- LUMO Health Care
- Exchange
- YYGH NYSE
- LUMO Nasdaq
- Market Cap
- YYGH 43.0M
- LUMO 37.7M
- IPO Year
- YYGH 2024
- LUMO N/A
- Fundamental
- Price
- YYGH $1.74
- LUMO $4.33
- Analyst Decision
- YYGH
- LUMO Buy
- Analyst Count
- YYGH 0
- LUMO 4
- Target Price
- YYGH N/A
- LUMO $9.38
- AVG Volume (30 Days)
- YYGH 48.0K
- LUMO 130.8K
- Earning Date
- YYGH 11-23-2024
- LUMO 11-07-2024
- Dividend Yield
- YYGH N/A
- LUMO N/A
- EPS Growth
- YYGH 527.44
- LUMO N/A
- EPS
- YYGH 0.04
- LUMO N/A
- Revenue
- YYGH $37,372,731.00
- LUMO $2,205,000.00
- Revenue This Year
- YYGH N/A
- LUMO $184.11
- Revenue Next Year
- YYGH N/A
- LUMO N/A
- P/E Ratio
- YYGH $43.28
- LUMO N/A
- Revenue Growth
- YYGH 55.18
- LUMO 300.59
- 52 Week Low
- YYGH $0.72
- LUMO $1.37
- 52 Week High
- YYGH $4.70
- LUMO $4.58
- Technical
- Relative Strength Index (RSI)
- YYGH N/A
- LUMO 56.58
- Support Level
- YYGH N/A
- LUMO $4.25
- Resistance Level
- YYGH N/A
- LUMO $4.44
- Average True Range (ATR)
- YYGH 0.00
- LUMO 0.11
- MACD
- YYGH 0.00
- LUMO -0.03
- Stochastic Oscillator
- YYGH 0.00
- LUMO 33.33
About YYGH YY GROUP HOLDING LIMITED
YY Group Holding Ltd is a data and technology driven company focused on developing enterprise intelligent labor matching services and smart cleaning services founded in Singapore. It provides enterprise manpower outsourcing and smart cleaning services in Singapore and Malaysia. The group has two operating segment, which is cleaning services segment and manpower outsourcing services, Maximum revenue is generated from cleaning services.
About LUMO Lumos Pharma Inc.
Lumos Pharma Inc is a biopharmaceutical company that develops treatments for cancer and rare diseases. It carries out both clinical-stage and preclinical research on a range of molecules that help the immune system fight off cancer cells. The treatments are available orally and can be used in conjunction with other cancer therapies. The company also researches an Ebola vaccine. Lumos contracts with manufacturing organizations to make their treatments, engages in partnerships with pharmaceutical companies, and operates in the United States.